Option Care Health, Inc.·4

May 5, 5:32 PM ET

KRAEMER HARRY M JANSEN JR 4

4 · Option Care Health, Inc. · Filed May 5, 2026

Research Summary

AI-generated summary of this filing

Updated

Option Care (OPCH) Director Harry M. Jansen Kraemer Jr. Buys Shares

What Happened
Harry M. Jansen Kraemer Jr., a director of Option Care Health, Inc. (OPCH), purchased 36,610 shares of the company's common stock in open-market transactions on May 4, 2026. The filing reports a weighted average purchase price of $21.41 per share for a total cash outlay of approximately $783,773. This was a purchase (acquisition) rather than a sale.

Key Details

  • Transaction date: May 4, 2026; Form 4 filed May 5, 2026 (appears timely).
  • Reported shares acquired: 36,610 at a weighted average price of $21.41; total value ≈ $783,773.
  • Reported price range: purchases occurred at prices between $21.35 and $21.475 per share (see footnote).
  • Footnote: F1 explains the $21.41 is a weighted average for multiple trades and that the filer will disclose the per-trade breakdown on request to the SEC, issuer, or security holder.
  • Shares owned after the transaction: not specified in the provided filing details.

Context
Open-market purchases by directors are direct purchases of company stock and are often monitored by investors as a potential positive signal, but they do not by themselves explain motivation (no inference should be made). This transaction is an outright purchase (code P) — not an option exercise, award, or gift — and the filing includes the usual footnote offering a per-trade price breakdown if requested.

Insider Transaction Report

Form 4
Period: 2026-05-04
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-05-04$21.41/sh+36,610$783,773450,000 total
Footnotes (1)
  • [F1]Reflects the weighted average price of 36,610 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.35 to $21.475 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Signature
/s/ Michael Bavaro, attorney-in-fact for Mr. Kraemer|2026-05-05

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4